StonvexLoading…
StonvexStonvexStonvexCore line items from CHCI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $17.45M | $62.86M | $38.93M | $25.61M |
Operating Income | $1.54M | $11.93M | $4.18M | $3.52M |
Net Income | $1.99M | $17.05M | $541.00K | $1.45M |
EPS (Diluted) | $0.19 | $1.63 | $0.34 | $0.29 |
Total Assets | $81.69M | $84.96M | $67.59M | $65.24M |
Total Liabilities | $9.88M | $15.00M | $11.33M | $9.79M |
Cash & Equivalents | $19.63M | $31.28M | $26.17M | $30.48M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 10.49M | 10.47M | 10.45M | 10.40M |